Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines

NIH RePORTER · NIH · N01 · $15,048,720 · view on reporter.nih.gov ↗

Abstract

The Objective of this task order supports NIAIDs goal to conduct a series of standardized phase 1 and phase 2 trials on next-generation vaccines to generate data to inform decisions on which candidate to advance.

Key facts

NIH application ID: 11042071
Project number: 75N91019D00024-P00001-759102300008-1
Recipient: LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator: KIRAN DATTA
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $15,048,720
Award type: —
Project period: 2023-06-01 → 2028-05-31